Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review

Dasatinib, a tyrosine kinase inhibitor, is widely used for patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Although the drug has a potent immunosuppressive effect, infectious complications during dasatinib treatment have been reported rarely....

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jae-Ki, Cho, Sung-Yeon, Choi, Su-Mi, Kim, Gyo Hui, Lee, Sung-Eun, Lee, Seok, Kim, Dong-Wook, Lee, Dong-Gun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031599/
https://www.ncbi.nlm.nih.gov/pubmed/29968984
http://dx.doi.org/10.3947/ic.2018.50.2.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031599/
https://www.ncbi.nlm.nih.gov/pubmed/29968984
http://dx.doi.org/10.3947/ic.2018.50.2.153

Ejemplares similares